P0454 Efficacy and safety of targeted-immunotherapy with or without stereotactic radiotherapy for recurrent/metastatic renal cell carcinoma: Interim analysis of a multicenter ambidirectional cohort study

European Urology 2026

View at publisher

Authors: K. Hu, M.W. Ma, X.S. Gao

DOI: 10.1016/s0302-2838(26)01341-2

Cited by: 0

Fields of Study & Subjects

Renal cell carcinoma treatment Cancer Immunotherapy and Biomarkers Bladder and Urothelial Cancer Treatments